Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy.
Ann Hematol
; 101(3): 621-630, 2022 Mar.
Article
en En
| MEDLINE
| ID: mdl-34816294
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Pirazoles
/
Pirimidinas
/
Esteroides
/
Proteínas Asociadas a Pancreatitis
/
Enfermedad Injerto contra Huésped
/
Nitrilos
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2022
Tipo del documento:
Article